NCT05036200View on ClinicalTrials.gov

Pilot Study to Evaluate the Interest of PDL in the Management of Telangiectasia of the Face and Neckline in Systemic Scleroderma

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

September 1, 2019

Study Completion Date

July 1, 2020

Conditions
Telangiectasia
Interventions
DEVICE

pulsed dye laser

four pulsed dye laser sessions were administered every eight weeks in the 21 patients

Trial Locations (1)

14000

Chu Caen Normandie, Caen

All Listed Sponsors
lead

University Hospital, Caen

OTHER

NCT05036200 - Pilot Study to Evaluate the Interest of PDL in the Management of Telangiectasia of the Face and Neckline in Systemic Scleroderma | Biotech Hunter | Biotech Hunter